Apollo Endosurgery, Inc.
APEN
APEN was delisted on the 3rd of April, 2023.
31 hedge funds and large institutions have $24M invested in Apollo Endosurgery, Inc. in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
7% more funds holding
Funds holding: 29 → 31 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
11% less capital invested
Capital invested by funds: $26.9M → $24M (-$2.91M)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$545K |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$461K |
| 3 |
GS
Gagnon Securities
New York
|
+$95.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$31.2K |
| 5 |
Renaissance Technologies
New York
|
+$11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$543K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$9.62K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$8K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$3.84K |
| 5 |
RWA
Ropes Wealth Advisors
Boston,
Massachusetts
|
-$2.9K |
APEN Hedge Fund Activity: Q4 2019 in Review
31 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q4 2019, worth a combined $24M — down 11% from $26.9M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new APEN positions and 4 closed out — a net gain of 2 holders — while 5 added to existing stakes and 8 trimmed.
The largest buyer was Stonepine Capital Management, adding an estimated $545K. The largest seller was Russell Investments Group, cutting an estimated $543K.
- 31 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q4 2019, up from 29 in Q3 2019.
- Funds reported $24M of Apollo Endosurgery, Inc. stock for Q4 2019, down 11% quarter-over-quarter.
- 6 funds opened new Apollo Endosurgery, Inc. positions in Q4 2019 and 4 closed out, a net change of +2 holders.
- The largest Apollo Endosurgery, Inc. buyer in Q4 2019 was Stonepine Capital Management, an estimated $545K added.
- The largest Apollo Endosurgery, Inc. seller in Q4 2019 was Russell Investments Group, an estimated $543K sold.
Based on aggregated 13F filings for Q4 2019.